Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Carbone

Showing results (591-600 of 651) with videos related to

Pageof 66
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 22, 2019
Identification of Recurrent Activating <i>HER2</i> Mutations in Primary Canine Pulmonary AdenocarcinomaGwendolen Lorch, Karthigayini Sivaprakasam, Victoria Zismann, et al.
European Journal of Cancer (Oxford, England : 1990)|September 13, 2024
Five-year outcomes with first-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus 4 cycles of chemotherapy alone in patients with metastatic non-small cell lung cancer in the randomized CheckMate 9LA trialMartin Reck, Tudor-Eliade Ciuleanu, Michael Schenker, et al.
Cancer Research|September 1, 1996
Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathologyT Tsukui, A Hildesheim, M H Schiffman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 19, 2018
Proteogenomic Analysis of Surgically Resected Lung AdenocarcinomaMichael F Sharpnack, Nilini Ranbaduge, Arunima Srivastava, et al.
Clinical Lung Cancer|July 27, 2025
Brief Report: Central Nervous System Metastases After Chemoradiation Followed by Durvalumab for Unresectable Locally Advanced Nonsmall Cell Lung CancerJohn Sharp, Philip Young, Songzhu Zhao, et al.
Cancer Immunology, Immunotherapy : CII|February 16, 2023
Mean platelet volume, thrombocytosis, and survival in non-small cell lung cancer patients treated with first-line pembrolizumab alone or with chemotherapyMingjia Li, Songzhu Zhao, Gabrielle Lopez, et al.
Journal for Immunotherapy of Cancer|May 9, 2019
Correction to: Determinant roles of dendritic cell-expressed Notch Delta-like and Jagged ligands on anti-tumor T-cell immunityElena E Tchekneva, Mounika U L Goruganthu, Roman V Uzhachenko, et al.
Journal for Immunotherapy of Cancer|April 4, 2019
Determinant roles of dendritic cell-expressed Notch Delta-like and Jagged ligands on anti-tumor T cell immunityElena E Tchekneva, Mounika U L Goruganthu, Roman V Uzhachenko, et al.
Journal of Geriatric Oncology|August 22, 2024
Resiliency among older adults receiving lung cancer treatment (ROAR-LCT): A novel supportive care intervention for older adults with advanced lung cancerCarolyn J Presley, Madison Grogan, Amy Compston, et al.
Cancer Research|April 14, 2011
Lung cancer diagnosis from proteomic analysis of preinvasive lesionsS M Jamshedur Rahman, Adriana L Gonzalez, Ming Li, et al.
Pageof 66

Showing results (591-600 of 651) with videos related to

Sort By:
Pageof 66
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 22, 2019
Identification of Recurrent Activating <i>HER2</i> Mutations in Primary Canine Pulmonary AdenocarcinomaGwendolen Lorch, Karthigayini Sivaprakasam, Victoria Zismann, et al.
European Journal of Cancer (Oxford, England : 1990)|September 13, 2024
Five-year outcomes with first-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus 4 cycles of chemotherapy alone in patients with metastatic non-small cell lung cancer in the randomized CheckMate 9LA trialMartin Reck, Tudor-Eliade Ciuleanu, Michael Schenker, et al.
Cancer Research|September 1, 1996
Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathologyT Tsukui, A Hildesheim, M H Schiffman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 19, 2018
Proteogenomic Analysis of Surgically Resected Lung AdenocarcinomaMichael F Sharpnack, Nilini Ranbaduge, Arunima Srivastava, et al.
Clinical Lung Cancer|July 27, 2025
Brief Report: Central Nervous System Metastases After Chemoradiation Followed by Durvalumab for Unresectable Locally Advanced Nonsmall Cell Lung CancerJohn Sharp, Philip Young, Songzhu Zhao, et al.
Cancer Immunology, Immunotherapy : CII|February 16, 2023
Mean platelet volume, thrombocytosis, and survival in non-small cell lung cancer patients treated with first-line pembrolizumab alone or with chemotherapyMingjia Li, Songzhu Zhao, Gabrielle Lopez, et al.
Journal for Immunotherapy of Cancer|May 9, 2019
Correction to: Determinant roles of dendritic cell-expressed Notch Delta-like and Jagged ligands on anti-tumor T-cell immunityElena E Tchekneva, Mounika U L Goruganthu, Roman V Uzhachenko, et al.
Journal for Immunotherapy of Cancer|April 4, 2019
Determinant roles of dendritic cell-expressed Notch Delta-like and Jagged ligands on anti-tumor T cell immunityElena E Tchekneva, Mounika U L Goruganthu, Roman V Uzhachenko, et al.
Journal of Geriatric Oncology|August 22, 2024
Resiliency among older adults receiving lung cancer treatment (ROAR-LCT): A novel supportive care intervention for older adults with advanced lung cancerCarolyn J Presley, Madison Grogan, Amy Compston, et al.
Cancer Research|April 14, 2011
Lung cancer diagnosis from proteomic analysis of preinvasive lesionsS M Jamshedur Rahman, Adriana L Gonzalez, Ming Li, et al.
Pageof 66